TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 3 | -2 | 1 | 2 | -6 | -37 | -7 |
| P | %wins | 100 | 0 | 50 | 50 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/5/22 16:12 | 8/31/22 | BIAF | Bioaffinity Technologies, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Knight Peter S | UT | D | P.d | 0 | 0.00 | 0 | 8 | 57 | 22 | D | |||||||||||||||
10/26/07 11:01 | 10/25/07 | PRX | Par Pharmaceutical Companies, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Knight Peter S | NJ | D | P | 45 | 18.09 | 26 | 3 | 250 | 4 | D | -21 | -8 | -33 | -22 | -7 | -7 | -7 | -2 | 3 | -3 | -2 | 9 | -4 | -46 | |
5/5/04 11:44 | 5/4/04 | PRX | Pharmaceutical Resources Inc | NJ | Health | Drug | Pharmaceutical Preparations | Knight Peter S | NY | D | P | 41 | 40.74 | 33 | 1 | New | 1 | D | 59 | -5 | -44 | -32 | -26 | -9 | -8 | -1 | 2 | -1 | 3 | -6 | -7 | -27 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |